135 related articles for article (PubMed ID: 19646965)
1. HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.
Matre V; Nordgård O; Alm-Kristiansen AH; Ledsaak M; Gabrielsen OS
Biochem Biophys Res Commun; 2009 Oct; 388(1):150-4. PubMed ID: 19646965
[TBL] [Abstract][Full Text] [Related]
2. FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.
Alm-Kristiansen AH; Saether T; Matre V; Gilfillan S; Dahle O; Gabrielsen OS
Oncogene; 2008 Aug; 27(34):4644-56. PubMed ID: 18408764
[TBL] [Abstract][Full Text] [Related]
3. c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.
Haas M; Siegert M; Schürmann A; Sodeik B; Wolfes H
Biochemistry; 2004 Jun; 43(25):8152-9. PubMed ID: 15209511
[TBL] [Abstract][Full Text] [Related]
4. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
Ladendorff NE; Wu S; Lipsick JS
Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
[TBL] [Abstract][Full Text] [Related]
5. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
6. The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin.
Bengtsen M; Sørensen L; Aabel L; Ledsaak M; Matre V; Gabrielsen OS
Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):751-760. PubMed ID: 28495617
[TBL] [Abstract][Full Text] [Related]
7. Constitutive c-Myb amino-terminal phosphorylation and DNA binding activity uncoupled during entry and passage through the cell cycle.
Cures A; House C; Kanei-Ishii C; Kemp B; Ramsay RG
Oncogene; 2001 Mar; 20(14):1784-92. PubMed ID: 11313925
[TBL] [Abstract][Full Text] [Related]
8. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
9. c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.
Aziz N; Wu J; Dubendorff JW; Lipsick JS; Sturgill TW; Bender TP
Oncogene; 1993 Aug; 8(8):2259-65. PubMed ID: 8336948
[TBL] [Abstract][Full Text] [Related]
10. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
[TBL] [Abstract][Full Text] [Related]
11. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
Dahle Ø; Bakke O; Gabrielsen OS
Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP.
Oelgeschläger M; Kowenz-Leutz E; Schreek S; Leutz A; Lüscher B
Oncogene; 2001 Nov; 20(50):7420-4. PubMed ID: 11704872
[TBL] [Abstract][Full Text] [Related]
13. p38MAPK delta controls c-Myb degradation in response to stress.
Pani E; Ferrari S
Blood Cells Mol Dis; 2008; 40(3):388-94. PubMed ID: 18006338
[TBL] [Abstract][Full Text] [Related]
14. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
[TBL] [Abstract][Full Text] [Related]
15. c-Myb inhibits myogenic differentiation through repression of MyoD.
Kaspar P; Pajer P; Sedlak D; Tamaoki T; Dvorak M
Exp Cell Res; 2005 Oct; 309(2):419-28. PubMed ID: 16055116
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases.
Bies J; Feiková S; Bottaro DP; Wolff L
Oncogene; 2000 Jun; 19(24):2846-54. PubMed ID: 10851088
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal protein L4 positively regulates activity of a c-myb proto-oncogene product.
Egoh A; Nosuke Kanesashi S; Kanei-Ishii C; Nomura T; Ishii S
Genes Cells; 2010 Aug; 15(8):829-41. PubMed ID: 20604807
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation-dependent conformation and proteolytic stability of c-Myb.
Bies J; Feiková S; Markus J; Wolff L
Blood Cells Mol Dis; 2001; 27(2):422-8. PubMed ID: 11259165
[TBL] [Abstract][Full Text] [Related]
19. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
20. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
